Business
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards
Recognition highlights EluPro™ Antibiotic-Eluting BioEnvelope’s impact on device protection for cardiac implantable electronic devices (CIEDs) and neurostimulators SILVER SPRING, Md., June 26, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, has been recognized with two prestigious honors—Innovation and Product Launches—in the 2025 Medical Device Network Excellence Awards. The awards celebrate Elutia’s advancements
About this update from Elutia, Inc.
[{"type":"image","alt":"Elutia Inc.","displaySize":"","headline":null,"caption":"Elutia Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":67,"url":"https://media.zenfs.com/en/globenewswire.com/a29e66fb8a73dd1618af733c91ecea76"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/c1mHLTLmof012jV7WnpAyg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/a29e66fb8a73dd1618af733c91ecea76","width":300,"height":67}},"lazy":false},{"type":"text","content":"Recognition highlights EluPro™ Antibiotic-Eluting BioEnvelope’s impact on device protection for cardiac implantable electronic devices (CIEDs) and neurostimulators","length":163,"tagName":"p"},{"type":"image","alt":"Elutia Medical Device Network Excellence Award Winner","displaySize":"","headline":null,"caption":"Elutia Medical Device Network Excellence Award Winner","className":"","disableSlideshowImg":false,"size":{"original":{"width":1080,"height":1920,"url":"https://media.zenfs.com/en/globenewswire.com/e59d8a6f3c3e1e5751e0178f9d3de4de"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LaNBP83ZSBzaDogrUtFA2w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE3MDc7Y2Y9d2VicA--/https://media.zenfs.com/en/globenewswire.com/e59d8a6f3c3e1e5751e0178f9d3de4de","width":960,"height":1707},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/3LPMqdIX5X6EXi_AZIh1OA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxNjA7aD0zODQwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/e59d8a6f3c3e1e5751e0178f9d3de4de","width":1080,"height":1920}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"SILVER SPRING, Md., June 26, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, has been recognized with two prestigious honors—Innovation and Product Launches—in the 2025 Medical Device Network Excellence Awards. The awards celebrate Elutia’s advancements in drug eluting bioenvelopes and the successful commercial introduction of EluPro.","length":419,"tagName":"p"},{"type":"text","content":"“We’re honored to receive recognition from Medical Device Network in both the Innovation and Product Launches categories,” said Dr. Randy Mills, CEO of Elutia. “These awards reflect the work of two exceptional groups at Elutia: our scientists and our go-to-market team. But the tr...